Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
The thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer. Highlighting the latest major advances in the field, the book includes chapters on t…
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 15548. (QZ200 B366 2006); European randomized trial of screening for prostate cancer by Dr. Chris Bangma; Strategy to avoid over treatment of early prostate cancer by Dr. Stijn Roemeling
c.1 BC Cancer Agency VAN Library AV Room | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
"This comprehensive book provides an overview of cancer therapeutics and covers different innovative treatment approaches for cancer. The initial chapter gives a detailed overview on cancer progression and disease diagnostics. The following chapters focus on different cancer treatment approaches, s…
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency SUR Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents; I. Etiology, pathology, and tumor biology -- II. Genetic susceptibility and hereditary predisposition, screening, and counseling -- III. Epidemiology -- IV. Prevention of prostate cancer -- V. Conservative management -- VI. Surgery -- VII. Radiation therapy -- VIII. Clinical dile…
c.1 BC Cancer Agency VAN Library AV Room | Available |
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
c.1 BC Cancer Agency ARHCC Library | Available |